Skip to main content

and
  1. No Access

    Article

    Vibrational spectroscopic techniques to assess bone quality

    Although musculoskeletal diseases such as osteoporosis are diagnosed and treatment outcome is evaluated based mainly on routine clinical outcomes of bone mineral density (BMD) by DXA and biochemical markers, i...

    E. P. Paschalis, S. Gamsjaeger, K. Klaushofer in Osteoporosis International (2017)

  2. No Access

    Article

    Effects of long-term alendronate treatment on postmenopausal osteoporosis bone material properties

    Raman microspectroscopic analysis of iliac crest from patients that were treated with alendronate (ALN) for 10 years revealed minimal, transient alterations in bone material properties confined to actively for...

    N. Hassler, S. Gamsjaeger, B. Hofstetter, W. Brozek in Osteoporosis International (2015)

  3. No Access

    Article

    Bone quality of the newest bone formed after two years of teriparatide therapy in patients who were previously treatment-naïve or on long-term alendronate therapy

    The results of the present study, involving analysis of biopsies from patients who received teriparatide for 2 years and were previously either treatment-naïve or on long-term alendronate therapy, suggest that...

    B. Hofstetter, S. Gamsjaeger, F. Varga, H. Dobnig in Osteoporosis International (2014)

  4. No Access

    Article

    Effects of 3 years treatment with once-yearly zoledronic acid on the kinetics of bone matrix maturation in osteoporotic patients

    Once-yearly administration of intravenous zoledronic acid for 3 years in humans affects the kinetics of matrix filling in by mineral, independent of bone turnover.

    S. Gamsjaeger, B. Hofstetter, E. Zwettler, R. Recker in Osteoporosis International (2013)

  5. No Access

    Article

    Fourier transform infrared analysis and bone

    E. P. Paschalis in Osteoporosis International (2009)